
Releases
GeneDx Investors Face August Deadline in Securities Fraud Class Action
Investors who held GeneDx Holdings Corp. stock during the past year face an August 3, 2026, deadline to join a class action lawsuit. The litigation centers on allegations that the company misled shareholders regarding the integration of Fabric Genomics, ultimately triggering a 49% single-day stock price collapse.






















